{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:43:07Z","timestamp":1787938987621,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00345-019-02811-w","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:19:39Z","timestamp":1558613979000},"page":"2279-2287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Consultation on UTUC, Stockholm 2018: aspects of treatment"],"prefix":"10.1007","volume":"37","author":[{"given":"Helene","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun","family":"Fajkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Baard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle J\u00f6rn Sloth","family":"Osther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-363X","authenticated-orcid":false,"given":"Marianne","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"issue":"1","key":"2811_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF (2018) European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.07.036","journal-title":"Eur Urol"},{"issue":"6","key":"2811_CR2","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/j.clgc.2016.04.017","volume":"14","author":"MM Elawdy","year":"2016","unstructured":"Elawdy MM, Taha DE, Elbaset MA, Abouelkheir RT, Osman Y (2016) Histopathologic characteristics of upper tract urothelial carcinoma with an emphasis on their effect on cancer survival: a single-institute experience with 305 patients with long-term follow-up. Clin Genitourin Cancer 14(6):e609\u2013e615. \n                    https:\/\/doi.org\/10.1016\/j.clgc.2016.04.017","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"2811_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.juro.2017.07.088","volume":"199","author":"L Villa","year":"2018","unstructured":"Villa L, Haddad M, Capitanio U, Somani BK, Cloutier J, Doizi S, Salonia A, Briganti A, Montorsi F, Traxer O (2018) Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium:YAG laser photoablation? Long-term results from a high volume institution. J Urol 199(1):66\u201373. \n                    https:\/\/doi.org\/10.1016\/j.juro.2017.07.088","journal-title":"J Urol"},{"issue":"11","key":"2811_CR4","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","volume":"110","author":"M Grasso","year":"2012","unstructured":"Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618\u20131626. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11066.x","journal-title":"BJU Int"},{"issue":"5","key":"2811_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int 110(5):614\u2013628. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11068.x","journal-title":"BJU Int"},{"issue":"3","key":"2811_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.urology.2011.11.049","volume":"79","author":"JK Wang","year":"2012","unstructured":"Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79(3):615\u2013619. \n                    https:\/\/doi.org\/10.1016\/j.urology.2011.11.049","journal-title":"Urology"},{"issue":"6","key":"2811_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.juro.2018.02.002","volume":"199","author":"EJ Margolin","year":"2018","unstructured":"Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V, Silver H, Clinton TN, Krabbe LM, Woldu SL, Singla N, Bagrodia A, Margulis V, Huang WC, Bjurlin MA, Shah O, Anderson CB (2018) Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma. J Urol 199(6):1440\u20131445. \n                    https:\/\/doi.org\/10.1016\/j.juro.2018.02.002","journal-title":"J Urol"},{"key":"2811_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.urology.2016.05.033","volume":"95","author":"G Vemana","year":"2016","unstructured":"Vemana G, Kim EH, Bhayani SB, Vetter JM, Strope SA (2016) Survival comparison between endoscopic and surgical management for patients with upper tract urothelial cancer: a matched propensity score analysis using surveillance, epidemiology and end results-medicare data. Urology 95:115\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.urology.2016.05.033","journal-title":"Urology"},{"issue":"6","key":"2811_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","volume":"70","author":"T Seisen","year":"2016","unstructured":"Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M, Bohle A, Burger M, Comperat EM, Cowan NC, Kaasinen E, Palou J, van Rhijn BW, Sylvester RJ, Zigeuner R, Shariat SF, Roupret M (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052\u20131068. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2016.07.014","journal-title":"Eur Urol"},{"key":"2811_CR10","unstructured":"USRDS (2010) United States renal data system 2010 annual data report. Atlas of chronic kidney disease and end-stage renal disease in the United States, Bethesda, MA (2010). National institutes of health, national institute of diabetes and digestive and kidney diseases"},{"issue":"3","key":"2811_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00345-016-1859-6","volume":"35","author":"RS Mandalapu","year":"2017","unstructured":"Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O\u2019Brien T, Zlotta A, Matin SF (2017) Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol 35(3):355\u2013365. \n                    https:\/\/doi.org\/10.1007\/s00345-016-1859-6","journal-title":"World J Urol"},{"issue":"3","key":"2811_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1464-410X.2009.09131.x","volume":"106","author":"Y Tada","year":"2010","unstructured":"Tada Y, Yokomizo A, Koga H, Seki N, Kuroiwa K, Tatsugami K, Yamaguchi A, Naito S (2010) Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and\/or holmium-YAG laser ablation. BJU Int 106(3):362\u2013366. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2009.09131.x","journal-title":"BJU Int"},{"issue":"6","key":"2811_CR13","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.juro.2012.12.006","volume":"189","author":"ML Cutress","year":"2013","unstructured":"Cutress ML, Stewart GD, Tudor EC, Egong EA, Wells-Cole S, Phipps S, Thomas BG, Riddick AC, McNeill SA, Tolley DA (2013) Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J Urol 189(6):2054\u20132060. \n                    https:\/\/doi.org\/10.1016\/j.juro.2012.12.006","journal-title":"J Urol"},{"issue":"9","key":"2811_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00345-015-1753-7","volume":"34","author":"L Villa","year":"2016","unstructured":"Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu JN, Montorsi F, Traxer O (2016) Early repeated ureteroscopy within 6\u20138\u00a0weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34(9):1201\u20131206. \n                    https:\/\/doi.org\/10.1007\/s00345-015-1753-7","journal-title":"World J Urol"},{"issue":"2","key":"2811_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bju.14053","volume":"121","author":"RQ Guo","year":"2018","unstructured":"Guo RQ, Hong P, Xiong GY, Zhang L, Fang D, Li XS, Zhang K, Zhou LQ (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184\u2013193. \n                    https:\/\/doi.org\/10.1111\/bju.14053","journal-title":"BJU Int"},{"issue":"3","key":"2811_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/end.2017.0915","volume":"32","author":"G Musi","year":"2018","unstructured":"Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S, Conti A, Luzzago S, Ferro M, Matei DV, Carmignani L, de Cobelli O (2018) Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes. J Endourol 32(3):257\u2013263. \n                    https:\/\/doi.org\/10.1089\/end.2017.0915","journal-title":"J Endourol"},{"issue":"3","key":"2811_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/jjco\/hyw179","volume":"47","author":"H Furuse","year":"2017","unstructured":"Furuse H, Matsushita Y, Yajima T, Kato T, Suzuki T, Matsumoto R, Motoyama D, Sugiyama T, Otsuka A, Ozono S (2017) Systematic regional lymph node dissection for upper tract urothelial carcinoma improves patient survival. Jpn J Clin Oncol 47(3):239\u2013246. \n                    https:\/\/doi.org\/10.1093\/jjco\/hyw179","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"2811_CR18","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.ejso.2016.08.008","volume":"42","author":"D Fang","year":"2016","unstructured":"Fang D, Seisen T, Yang K, Liu P, Fan X, Singla N, Xiong G, Zhang L, Li X, Zhou L (2016) A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol 42(11):1625\u20131635. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2016.08.008","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"2811_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martinez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61(4):818\u2013825. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2012.01.021","journal-title":"Eur Urol"},{"issue":"12","key":"2811_CR20","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.25043","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D, Dreicer R, Hansel DE, Stephenson AJ (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116(12):2967\u20132973. \n                    https:\/\/doi.org\/10.1002\/cncr.25043","journal-title":"Cancer"},{"issue":"2","key":"2811_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.ju.0000148851.68215.93","volume":"173","author":"SF Matin","year":"2005","unstructured":"Matin SF, Gill IS (2005) Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol 173(2):395\u2013400. \n                    https:\/\/doi.org\/10.1097\/01.ju.0000148851.68215.93","journal-title":"J Urol"},{"issue":"1","key":"2811_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.eururo.2012.04.052","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma C (2014) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 65(1):210\u2013217. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2012.04.052","journal-title":"Eur Urol"},{"issue":"5","key":"2811_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.eururo.2010.08.005","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, Bochner BH, Coleman J, Dalbagni G (2010) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58(5):645\u2013651. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2010.08.005","journal-title":"Eur Urol"},{"issue":"3","key":"2811_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1464-410X.2010.09826.x","volume":"108","author":"TJ Walton","year":"2011","unstructured":"Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martinez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF (2011) Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int 108(3):406\u2013412. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09826.x","journal-title":"BJU Int"},{"issue":"9","key":"2811_CR25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1464-410X.2009.08594.x","volume":"104","author":"F Greco","year":"2009","unstructured":"Greco F, Wagner S, Hoda RM, Hamza A, Fornara P (2009) Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up. BJU Int 104(9):1274\u20131278. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08594.x","journal-title":"BJU Int"},{"issue":"3","key":"2811_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","volume":"56","author":"G Simone","year":"2009","unstructured":"Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, Gallucci M (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56(3):520\u2013526. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2009.06.013","journal-title":"Eur Urol"},{"key":"2811_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.10.003","author":"B Peyronnet","year":"2017","unstructured":"Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, Maclennan S, N\u2019Dow J, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Mostafid H, van Rhijn BWG, Gontero P, Palou J, Shariat SF, Roupret M (2017) Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review. Eur Urol Focus. \n                    https:\/\/doi.org\/10.1016\/j.euf.2017.10.003","journal-title":"Eur Urol Focus"},{"issue":"10","key":"2811_CR28","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00345-017-2026-4","volume":"35","author":"M Moschini","year":"2017","unstructured":"Moschini M, Foerster B, Abufaraj M, Soria F, Seisen T, Roupret M, Colin P, De la Taille A, Peyronnet B, Bensalah K, Herout R, Wirth MP, Novotny V, Chlosta P, Bandini M, Montorsi F, Simone G, Gallucci M, Romeo G, Matsumoto K, Karakiewicz P, Briganti A, Shariat SF (2017) Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World J Urol 35(10):1541\u20131547. \n                    https:\/\/doi.org\/10.1007\/s00345-017-2026-4","journal-title":"World J Urol"},{"issue":"6","key":"2811_CR29","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.juro.2009.02.021","volume":"181","author":"M Roscigno","year":"2009","unstructured":"Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernandez MI, Mikami S, Isida M, Michel MS, Montorsi F (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482\u20132489. \n                    https:\/\/doi.org\/10.1016\/j.juro.2009.02.021","journal-title":"J Urol"},{"issue":"5","key":"2811_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/iju.12417","volume":"21","author":"T Kondo","year":"2014","unstructured":"Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, Iizuka J, Omae K, Yoshida K, Tanabe K (2014) Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study. Int J Urol 21(5):453\u2013459. \n                    https:\/\/doi.org\/10.1111\/iju.12417","journal-title":"Int J Urol"},{"issue":"6","key":"2811_CR31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1464-410x.2007.07114.x","volume":"100","author":"H Suttmann","year":"2007","unstructured":"Suttmann H, Kamradt J, Lehmann J, Stockle M (2007) Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection. BJU Int 100(6):1221\u20131224. \n                    https:\/\/doi.org\/10.1111\/j.1464-410x.2007.07114.x","journal-title":"BJU Int"},{"key":"2811_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.047","author":"JE Gschwend","year":"2018","unstructured":"Gschwend JE, Heck MM, Lehmann J, Rubben H, Albers P, Wolff JM, Frohneberg D, de Geeter P, Heidenreich A, Kalble T, Stockle M, Schnoller T, Stenzl A, Muller M, Truss M, Roth S, Liehr UB, Leissner J, Bregenzer T, Retz M (2018) Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur Urol. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2018.09.047","journal-title":"Eur Urol"},{"issue":"1","key":"2811_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2005.09.010","volume":"49","author":"P Marits","year":"2006","unstructured":"Marits P, Karlsson M, Sherif A, Garske U, Thorn M, Winqvist O (2006) Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol 49(1):59\u201370. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2005.09.010","journal-title":"Eur Urol"},{"issue":"6","key":"2811_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.eururo.2018.06.048","volume":"74","author":"D Krantz","year":"2018","unstructured":"Krantz D, Hartana CA, Winerdal ME, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Zirakzadeh AA, Holmstrom B, Riklund K, Sherif A, Winqvist O (2018) Neoadjuvant chemotherapy reinforces antitumour T cell response in urothelial urinary bladder cancer. Eur Urol 74(6):688\u2013692. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2018.06.048","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"2811_CR35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.juro.2007.05.158","volume":"178","author":"T Kondo","year":"2007","unstructured":"Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K (2007) Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 178(4 Pt 1):1212\u20131217. \n                    https:\/\/doi.org\/10.1016\/j.juro.2007.05.158\n                    \n                  \n                           (discussion 1217)","journal-title":"J Urol"},{"issue":"3","key":"2811_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.eururo.2009.06.004","volume":"56","author":"M Roscigno","year":"2009","unstructured":"Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Bensalah K, Raman JD, Bolenz C, Kassou W, Koppie TM, Wood CG, Wheat J, Langner C, Ng CK, Capitanio U, Bertini R, Fernandez MI, Mikami S, Isida M, Strobel P, Montorsi F (2009) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56(3):512\u2013518. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2009.06.004","journal-title":"Eur Urol"},{"issue":"10","key":"2811_CR37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1442-2042.2010.02610.x","volume":"17","author":"T Kondo","year":"2010","unstructured":"Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F, Tanabe K (2010) Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol 17(10):848\u2013854. \n                    https:\/\/doi.org\/10.1111\/j.1442-2042.2010.02610.x","journal-title":"Int J Urol"},{"issue":"3","key":"2811_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000350508","volume":"91","author":"D Fang","year":"2013","unstructured":"Fang D, Li XS, Xiong GY, Yao L, He ZS, Zhou LQ (2013) Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. Urol Int 91(3):291\u2013296. \n                    https:\/\/doi.org\/10.1159\/000350508","journal-title":"Urol Int"},{"issue":"11","key":"2811_CR39","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, Kawamura S, Aoki H, Numata I, Takeda A, Namiki S, Namima T, Ikeda Y, Kambe K, Kyan A, Ueno S, Orikasa K, Katoh S, Adachi H, Tokuyama S, Ishidoya S, Yamaguchi T, Arai Y (2013) Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol 31(11):1422\u20131427. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.45.2128","journal-title":"J Clin Oncol"},{"issue":"4","key":"2811_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of O (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60(4):703\u2013710. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2011.05.064","journal-title":"Eur Urol"},{"issue":"5","key":"2811_CR41","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0022-5347(01)64793-1","volume":"157","author":"FX Keeley Jr","year":"1997","unstructured":"Keeley FX Jr, Bibbo M, Bagley DH (1997) Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 157(5):1560\u20131565","journal-title":"J Urol"},{"issue":"2","key":"2811_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.juro.2016.03.194","volume":"197","author":"GP Redrow","year":"2017","unstructured":"Redrow GP, Guo CC, Brausi MA, Coleman JA, Fernandez MI, Kassouf W, Keeley FX Jr, Margulis V, Raman JD, Roupret M, Shariat SF, Spiess PE, Thalmann GN, Matin SF (2017) Upper urinary tract carcinoma in situ: current knowledge, future direction. J Urol 197(2):287\u2013295. \n                    https:\/\/doi.org\/10.1016\/j.juro.2016.03.194","journal-title":"J Urol"},{"issue":"5","key":"2811_CR43","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","volume":"60","author":"G Giannarini","year":"2011","unstructured":"Giannarini G, Kessler TM, Birkhauser FD, Thalmann GN, Studer UE (2011) Antegrade perfusion with Bacillus Calmette\u2013Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol 60(5):955\u2013960. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2011.07.051","journal-title":"Eur Urol"},{"issue":"6","key":"2811_CR44","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1590\/S1677-5538.IBJU.2016.0258","volume":"43","author":"Z Liu","year":"2017","unstructured":"Liu Z, Ng J, Yuwono A, Lu Y, Tan YK (2017) Which is best method for instillation of topical therapy to the upper urinary tract? An in vivo porcine study to evaluate three delivery methods. Int Braz J Urol 43(6):1084\u20131091. \n                    https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0258","journal-title":"Int Braz J Urol"},{"issue":"6","key":"2811_CR45","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.urology.2013.08.048","volume":"82","author":"ME Pollard","year":"2013","unstructured":"Pollard ME, Levinson AW, Shapiro EY, Cha DY, Small AC, Mohamed NE, Badani KK, Gupta M (2013) Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model. Urology 82(6):1451\u20131456. \n                    https:\/\/doi.org\/10.1016\/j.urology.2013.08.048","journal-title":"Urology"},{"issue":"6","key":"2811_CR46","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.eururo.2008.03.092","volume":"54","author":"H Jung","year":"2008","unstructured":"Jung H, Norby B, Frimodt-Moller PC, Osther PJ (2008) Endoluminal isoproterenol irrigation decreases renal pelvic pressure during flexible ureterorenoscopy: a clinical randomized, controlled study. Eur Urol 54(6):1404\u20131413. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2008.03.092","journal-title":"Eur Urol"},{"key":"2811_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s40064-015-1114-4","volume":"4","author":"H Jung","year":"2015","unstructured":"Jung H, Osther PJ (2015) Intraluminal pressure profiles during flexible ureterorenoscopy. SpringerPlus 4:373. \n                    https:\/\/doi.org\/10.1186\/s40064-015-1114-4","journal-title":"SpringerPlus"},{"issue":"5","key":"2811_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/17512433.2018.1461560","volume":"11","author":"JJ Knoedler","year":"2018","unstructured":"Knoedler JJ, Raman JD (2018) Intracavitary therapies for upper tract urothelial carcinoma. Expert Rev Clin Pharmacol 11(5):487\u2013493. \n                    https:\/\/doi.org\/10.1080\/17512433.2018.1461560","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"9","key":"2811_CR49","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/end.2016.0871","volume":"31","author":"M Metcalfe","year":"2017","unstructured":"Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF (2017) Induction and maintenance adjuvant mitomycin C topical therapy for upper tract urothelial carcinoma: tolerability and intermediate term outcomes. J Endourol 31(9):946\u2013953. \n                    https:\/\/doi.org\/10.1089\/end.2016.0871","journal-title":"J Endourol"},{"issue":"1","key":"2811_CR50","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/S1569-9056(14)60027-0","volume":"13","author":"D Lifshitz","year":"2014","unstructured":"Lifshitz D (2014) Hydrogel based drug retention system for the treatment of upper tract urothelial carcinoma. Eur Urol Suppl 13(1):e25","journal-title":"Eur Urol Suppl"},{"issue":"1\u20132","key":"2811_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijpharm.2016.08.061","volume":"513","author":"AA Barros","year":"2016","unstructured":"Barros AA, Browne S, Oliveira C, Lima E, Duarte AR, Healy KE, Reis RL (2016) Drug-eluting biodegradable ureteral stent: new approach for urothelial tumors of upper urinary tract cancer. Int J Pharm 513(1\u20132):227\u2013237. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2016.08.061","journal-title":"Int J Pharm"},{"key":"2811_CR52","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/TCRM.S158753","volume":"14","author":"D Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P (2018) Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook. Ther Clin Risk Manag 14:1019\u20131040. \n                    https:\/\/doi.org\/10.2147\/TCRM.S158753","journal-title":"Ther Clin Risk Manag"},{"key":"2811_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.11.023","author":"JL Perez-Gracia","year":"2017","unstructured":"Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Duran I, Theodore C, Grande E, Shen X, Wang J, Nelson B, Derleth CL, van der Heijden MS (2017) Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: outcomes by prior number of regimens. Eur Urol. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2017.11.023","journal-title":"Eur Urol"},{"issue":"5","key":"2811_CR54","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.juro.2017.11.068","volume":"199","author":"M Moschini","year":"2018","unstructured":"Moschini M, Shariat SF, Roupret M, De Santis M, Bellmunt J, Sternberg CN, Tombal B, Collette L (2018) Impact of primary tumor location on survival from the European Organization for the research and treatment of cancer advanced urothelial cancer studies. J Urol 199(5):1149\u20131157. \n                    https:\/\/doi.org\/10.1016\/j.juro.2017.11.068","journal-title":"J Urol"},{"issue":"11","key":"2811_CR55","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF, Investigators K (2017) Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med 376(11):1015\u20131026. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1613683","journal-title":"N Engl J Med"},{"issue":"1","key":"2811_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","volume":"68","author":"C Kwak","year":"2006","unstructured":"Kwak C, Lee SE, Jeong IG, Ku JH (2006) Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68(1):53\u201357. \n                    https:\/\/doi.org\/10.1016\/j.urology.2006.01.053","journal-title":"Urology"},{"issue":"2","key":"2811_CR57","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bju.14020","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi A, Lo Vullo S, Mariani L, Moschini M, Hendricksen K, Rink M, Sosnowski R, Dobruch J, Raman JD, Wood CG, Margulis V, Roupret M, Briganti A, Montorsi F, Xylinas E, Shariat SF, European Association of Urology-Young Academic Urologists UCG, the Upper Tract Urothelial Carcinoma Collaboration G (2018) Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 121(2):252\u2013259. \n                    https:\/\/doi.org\/10.1111\/bju.14020","journal-title":"BJU Int"},{"issue":"5","key":"2811_CR58","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.eururo.2016.11.012","volume":"71","author":"T Seisen","year":"2017","unstructured":"Seisen T, Jindal T, Karabon P, Sood A, Bellmunt J, Roupret M, Leow JJ, Vetterlein MW, Sun M, Alanee S, Choueiri TK, Trinh QD, Menon M, Abdollah F (2017) Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma. Eur Urol 71(5):714\u2013718. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2016.11.012","journal-title":"Eur Urol"},{"issue":"60","key":"2811_CR59","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.18632\/oncotarget.21551","volume":"8","author":"Y Kubota","year":"2017","unstructured":"Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C (2017) Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study. Oncotarget 8(60):101500\u2013101508. \n                    https:\/\/doi.org\/10.18632\/oncotarget.21551","journal-title":"Oncotarget"},{"issue":"12","key":"2811_CR60","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP, Matin SF (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794\u20131799. \n                    https:\/\/doi.org\/10.1002\/cncr.28655","journal-title":"Cancer"},{"issue":"6","key":"2811_CR61","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.euf.2017.03.013","volume":"4","author":"S Hosogoe","year":"2018","unstructured":"Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C (2018) Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma. Eur Urol Focus 4(6):946\u2013953. \n                    https:\/\/doi.org\/10.1016\/j.euf.2017.03.013","journal-title":"Eur Urol Focus"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02811-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:11:15Z","timestamp":1590102675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02811-w","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}